Higher Physical Activity Tracks With Slower Parkinson’s Decline
A seven-year observational study in Parkinson’s disease points to a pattern clinicians have long hoped to see more clearly: people who stayed more physically active tended to lose cognitive and motor function more slowly. The association was seen across memory, thinking, and movement, with the most active participants showing the smallest average decline over time. In practical terms, regular exercise looked linked not only to better mobility but also to preservation of higher brain function, two domains that often erode together as Parkinson’s advances.
The study, published in Neurology, followed 294 adults with mild to moderate Parkinson’s disease for as long as seven years. Participants were 66 years old on average. Each year, they completed cognitive testing and movement assessments, while their weekly physical activity was estimated through questionnaires covering work, home chores, and recreation. The design does not prove cause and effect, but it provides a long runway for watching how activity habits line up with the trajectory of a neurodegenerative illness.
One result stood out immediately.
Among participants doing more than eight hours of activity per week, average cognitive scores were essentially flat over time.
Cognitive Scores Stayed Near Baseline in the Most Active Group
Researchers used a 30-point test of thinking and memory, where lower scores reflect worse function. In the least active group, scores declined by an estimated 0.478 points per year. The moderately active group declined by 0.090 points per year. In the most active group, the estimated annual decrease was only 0.007 points, a change so small it suggests near stability across the follow-up period.
The pattern matters because cognition in Parkinson’s disease is not a side issue. Memory and executive dysfunction can erode independence, complicate medication management, and force earlier reliance on caregivers. A small annual difference can compound over years, particularly in a disorder where patients may live with symptoms for a long time. Even modest slowing of decline may alter the timing of real-world losses in function.
The activity signal was not confined to a single way of measuring movement. Investigators looked at total activity time, overall activity volume that weighted intensity, and time spent in vigorous exercise. Each measure lined up with slower deterioration in both cognition and motor symptoms. That consistency strengthens the clinical relevance of the association, because it suggests the relationship is not an artifact of one narrowly defined exercise metric.
Motor Symptoms Also Moved More Slowly in Active Participants
Movement outcomes were measured with a scale ranging from 0 to 132, where higher scores indicate more severe Parkinsonian symptoms. Participants began the study with an average score of 23. In the least active group, scores increased by an estimated 0.143 points per year, signaling gradual worsening. The moderately active group showed a decrease of 0.225 points per year, while the most active group showed a larger decrease of 0.783 points per year.
This finding raises a biologically plausible possibility: regular physical activity may support neural circuits involved in gait, balance, and bradykinesia while also preserving cortical networks tied to cognition. Exercise influences dopamine signaling, vascular health, inflammation, mitochondrial function, and synaptic plasticity, all of which are relevant to Parkinson’s disease. The observed pattern does not isolate one mechanism, but it fits a disease model in which movement itself may help sustain the very systems that are breaking down.
Even after adjustment for age, sex, and duration of Parkinson’s disease, the most active participants still had slower cognitive decline and less motor worsening than the least active participants. The association persisted across measures of activity intensity and duration, which matters because vigorous exercise may impose greater cardiometabolic and neuromuscular stress than lighter movement. The data suggest a dose-related pattern rather than a simple yes-or-no exercise effect.
How the Activity Exposure Was Measured
Physical activity was estimated from self-report rather than direct wearable monitoring, and that limitation sits at the center of how the results should be interpreted. Participants described hours spent on moderate and vigorous activities at work, home, and during leisure time. Moderate activity included brisk walking, doubles tennis, leisurely swimming, and household tasks such as vacuuming or mowing the lawn. More vigorous efforts included running, faster cycling, team sports, singles tennis, shoveling, and carrying heavy objects.
From those responses, researchers built three exposure measures: total time spent in moderate or vigorous activity, overall activity volume with heavier weighting for more strenuous exercise, and time spent specifically in vigorous activity. Based on total weekly hours, participants were categorized as least active at up to four hours, moderately active at four to eight hours, and most active at more than eight hours per week. These groups gave the analysis a practical clinical shape, because the difference between a mostly sedentary week and a routine filled with regular movement is easy to understand at the bedside.
Still, self-report can overestimate or underestimate actual activity, especially in older adults and in patients whose symptoms fluctuate. Exercise habits may also track with other healthy behaviors, including better nutrition, stronger social support, and more consistent access to care. Those factors could partly explain why the active group fared better, even though the adjustment for age, sex, and disease duration narrowed some of that concern.
What Neurologists Should Take From the Findings
The study adds weight to the idea that staying active over time may matter as Parkinson’s progresses, not only near diagnosis but across years of disease. The benefit appears broad rather than confined to a single domain, with linked slowing in both cognition and movement. For patients, that translates into a straightforward clinical message: sustained activity may be one of the few modifiable behaviors associated with a slower functional slide.
Caution remains necessary. The cohort started with relatively good cognitive function, so the results may not apply in the same way to patients with more advanced impairment or established dementia. The study also cannot prove that exercise itself caused the slower decline. Randomized trials with objective activity tracking would be needed to settle that question.
Funding came from the Gardner Family Foundation and the Precision Medicine in Neurodegenerative Diseases Fund. The paper, “Physical Activity and Motor and Cognitive Progression in Parkinson Disease,” was published in Neurology with Dong-Woo Ryu, MD, PhD, and colleagues listed as authors. For now, the most concrete reading is also the simplest: in Parkinson’s disease, more movement tracked with slower loss of both mind and motion, and the difference widened across years rather than months.